Abstract
The global outlook series on Biotechnology provides a collection of
statistical anecdotes, market briefs, and concise summaries of research
findings. The report offers a bird' s eye view of the Biotechnology industry.
Annotated with 26 fact, and data rich tables presenting analytical
segmentation by product application, the report provides global revenues, and
expenditure on R&D of/by biotechnology companies, sales of enabling
technologies, biologic drug sales by product and global
biotech/pharmacogenomics/bioinformatics product/technology sales, among
others. The report offers a sneak peek into major end-use industries, taking
note of select trends in Genomics, Biochips, Biologics and Biopharmaceutical
Intermediates, Biogenerics, Biotechnology Instruments, and Biotechnology
Reagents, among others. Also included is a compilation of all recent mergers,
acquisitions, and strategic corporate developments. A regional-level of
discussion mirrors the prevalent scenario in key regional markets such as the
US, Canada, Mexico, Japan, France, Germany, Poland, UK, Sweden, Switzerland,
New Zealand, India, Malaysia, and Brazil, among few others. The report also
includes an indexed, easy-to-refer, fact-finder directory listing the
addresses, and contact details of 2,220 companies worldwide.
| 
View Cart
